Home/Filings/3/0001209191-20-050608
3//SEC Filing

venBio Global Strategic Fund, L.P. 3

Accession 0001209191-20-050608

CIK 0001634379other

Filed

Sep 14, 8:00 PM ET

Accepted

Sep 15, 8:55 PM ET

Size

14.2 KB

Accession

0001209191-20-050608

Insider Transaction Report

Form 3
Period: 2020-09-15
Holdings
  • Series B Convertible Preferred Stock

    Common Stock (472,250 underlying)
  • Series A Convertible Preferred Stock

    Common Stock (1,960,784 underlying)
  • Series C Convertible Preferred Stock

    Common Stock (396,089 underlying)
Holdings
  • Series B Convertible Preferred Stock

    Common Stock (472,250 underlying)
  • Series A Convertible Preferred Stock

    Common Stock (1,960,784 underlying)
  • Series C Convertible Preferred Stock

    Common Stock (396,089 underlying)
GOODMAN COREY S
10% OwnerOther
Holdings
  • Series A Convertible Preferred Stock

    Common Stock (1,960,784 underlying)
  • Series B Convertible Preferred Stock

    Common Stock (472,250 underlying)
  • Series C Convertible Preferred Stock

    Common Stock (396,089 underlying)
Holdings
  • Series A Convertible Preferred Stock

    Common Stock (1,960,784 underlying)
  • Series B Convertible Preferred Stock

    Common Stock (472,250 underlying)
  • Series C Convertible Preferred Stock

    Common Stock (396,089 underlying)
Footnotes (2)
  • [F1]Every 5.1 shares of Series A Convertible Preferred Stock, Series B Convertible Preferred Stock and Series C Convertible Preferred Stock (collectively, the "Preferred Stock") are convertible into 1 share of Common Stock upon the closing of the Issuer's initial public offering. Share numbers give effect to such conversion. The Preferred Stock has no expiration date.
  • [F2]The shares are held by venBio Global Strategic Fund, L.P. venBio Global Strategic GP, L.P. is the general partner of venBio Global Strategic Fund, L.P. and venBio Global Strategic GP, Ltd. is the general partner of venBio Global Strategic GP, L.P. Corey Goodman is a director of venBio Global Strategic GP, Ltd. Each of venBio Global Strategic GP, L.P., venBio Global Strategic GP, Ltd. and Mr. Goodman disclaims beneficial ownership of such securities, except to the extent of its/his indirect pecuniary interest therein.

Issuer

Metacrine, Inc.

CIK 0001634379

Entity typeother
IncorporatedCayman Islands

Related Parties

1
  • filerCIK 0001504130

Filing Metadata

Form type
3
Filed
Sep 14, 8:00 PM ET
Accepted
Sep 15, 8:55 PM ET
Size
14.2 KB